Contact Us
Contact Us

News & Insight

•2025-07-28•

The medical device registration application of Bonvadis® for all indications in wounds has been accepted by Morocco AMMPS.

Oneness has received notification from the agent today that the medical device registration applicat...
Read More
•2025-06-10•

Today, Bonvadis® is 510(k) cleared by the U.S. FDA for full-thickness chronic wounds, marking a significant milestone in international commercialization.

After a three-year, three-phase application process, our product has obtained 510(k) clearances in t...
Read More
•2025-05-21•

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds for Australia.

Oneness has received notification from the agent today that the product topical cream received medic...
Read More
•2025-05-09•

The medical device registration application of Bonvadis® for all indications in wounds has been accepted by India CDSCO.

According to Invest India, the country’s medical device market is valued at approximately USD 11 bil...
Read More
•2025-04-23•

The medical device registration application of Bonvadis® for all indications in wounds has been accepted by Egypt EDA. 

With a population of approximately 108 million and a diabetic population of approximately 11 million...
Read More
•2025-04-16•

The medical device registration application of Bonvadis® for all indications in wounds has been accepted by Australia TGA.

The demand for wound care products in Australia continues to grow steadily. According to the Interna...
Read More
•2025-04-10•

Oneness has submitted 510(k) application of Bonvadis® for full thickness wound indications to the U.S. FDA.

According to the statistics of Reportlinker.com, the global market of advanced wound care products w...
Read More
•2025-04-03•

The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Brazil ANVISA. 

The demand for wound care products in Brazil is showing steady growth. According to a market report,...
Read More
•2025-03-25•

Oneness Biotech Co., Ltd., has been granted the Brazil Good Manufacturing Practice (B-GMP) certification for Bonvadis® from Brazil ANVISA.

Oneness received the notification today from the agent that our product has passed the Brazilian Goo...
Read More
1 2